Clinical and microbiological features of Providencia bacteremia: experience at a tertiary care hospital

The Korean Journal of Internal Medicine
Hee Kyoung ChoiYoung Uh

Abstract

Providencia species frequently colonize urinary catheters and cause urinary tract infections (UTIs); however, bacteremia is uncommon and not well understood. We investigated the clinical features of Providencia bacteremia and the antibiotic susceptibility of Providencia species. We identified cases of Providencia bacteremia from May 2001 to April 2013 at a tertiary care hospital. The medical records of pertinent patients were reviewed. Fourteen cases of Providencia bacteremia occurred; the incidence rate was 0.41 per 10,000 admissions. The median age of the patients was 64.5 years. Eleven cases (78.6%) were nosocomial infections and nine cases (64.3%) were polymicrobial bacteremia. The most common underlying conditions were cerebrovascular/neurologic disease (n = 10) and an indwelling urinary catheter (n = 10, 71.4%). A UTI was the most common source of bacteremia (n = 5, 35.7%). The overall mortality rate was 29% (n = 4); in each case, death occurred within 4 days of the onset of bacteremia. Primary bacteremia was more fatal than other types of bacteremia (mortality rate, 75% [3/4] vs. 10% [1/10], p = 0.041). The underlying disease severity, Acute Physiologic and Chronic Health Evaluation II scores, and Pitt bacteremia scores ...Continue Reading

References

Dec 1, 1992·Infection and Immunity·M J AlbertJ Montanaro
Aug 1, 1995·The Journal of Antimicrobial Chemotherapy·R J FassL W Ayers
Feb 1, 1996·Southern Medical Journal·T D Woods, C Watanakunakorn
Mar 13, 1999·International Journal of Antimicrobial Agents·J W Chow, V L Yu
Apr 16, 2003·Scandinavian Journal of Infectious Diseases·Baek-Nam KimJiso Ryu
Dec 23, 2003·The Journal of Antimicrobial Chemotherapy·Mario TumbarelloRoberto Cauda
Dec 29, 2004·International Journal of Antimicrobial Agents·Jian LiKingsley Coulthard
Sep 30, 2005·Journal of Medical Microbiology·Katsuaki ShirotoKeizo Yamaguchi
Sep 30, 2005·Journal of Medical Microbiology·Myonsun YohTakeshi Honda
Jul 26, 2006·Pharmacotherapy·Warren E Rose, Michael J Rybak
Nov 11, 2009·Antimicrobial Agents and Chemotherapy·Frédéric RobinRichard Bonnet
Nov 9, 2010·The Journal of Infection·Cheol-In KangUNKNOWN Korean Network for Study of Infectious Diseases (KONSID)
May 9, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alexandre P ZavasckiAna C Gales

❮ Previous
Next ❯

Citations

Sep 25, 2017·Applied and Environmental Microbiology·Hugo OliveiraJoana Azeredo
Sep 25, 2019·Annals of the New York Academy of Sciences·Nontombi Marylucy MbelleCharles Feldman
Mar 10, 2015·The Korean Journal of Internal Medicine·Seong-Heon Wie
Jul 18, 2018·Polish Journal of Microbiology·Hanieh AsaadiSaeed Tajbakhsh

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.